StockData
Actuate Therapeutics, Inc. logo

Actuate Therapeutics, Inc. (ACTU) stock

ACTUNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.25−0.02 (-6.12%)

Close on Nov 17, 2026Market cap $6.04MP/E –Yield –

Actuate Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Actuate Therapeutics's market cap was $7.26M on Nov 11, 2026, against $177.35M a year earlier. Over the last 2 years it ranged from $7.26M to $232.43M, with a median of $119.34M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$7.26M-94.9%
2025Dec 31, 2025$142.25M-8.5%
2024Dec 31, 2024$155.47M–

More Actuate Therapeutics figures

See a number that looks wrong?